
OpenProtein.AI is a Singapore-based company providing a machine learning-driven platform for protein engineering. Their flagship product, PoET-2, is a next-generation foundation model that enables the design of optimized protein variant libraries to accelerate research projects, reduce costs, and improve outcomes in fewer experimental rounds. The platform supports sequence-to-function prediction, mutagenesis hotspot mapping, and multi-objective library design, integrating seamlessly with existing workflows and removing IT infrastructure burdens by providing GPU resources. OpenProtein.AI's technology leverages large-scale AI models trained on natural protein sequences and experimental data to generate novel, functional proteins with enhanced properties, validated across diverse protein families and functions. The company emphasizes accessible AI, open science, and hands-on assistance to democratize advanced protein design, serving customers in biotech and pharmaceutical sectors.

OpenProtein.AI is a Singapore-based company providing a machine learning-driven platform for protein engineering. Their flagship product, PoET-2, is a next-generation foundation model that enables the design of optimized protein variant libraries to accelerate research projects, reduce costs, and improve outcomes in fewer experimental rounds. The platform supports sequence-to-function prediction, mutagenesis hotspot mapping, and multi-objective library design, integrating seamlessly with existing workflows and removing IT infrastructure burdens by providing GPU resources. OpenProtein.AI's technology leverages large-scale AI models trained on natural protein sequences and experimental data to generate novel, functional proteins with enhanced properties, validated across diverse protein families and functions. The company emphasizes accessible AI, open science, and hands-on assistance to democratize advanced protein design, serving customers in biotech and pharmaceutical sectors.